Medicine and Dentistry
Juvenile Myelomonocytic Leukemia
100%
Tipifarnib
100%
Therapeutic Procedure
100%
Bone Marrow
100%
Spontaneous Remission
66%
Transplantation
66%
Clofarabine
66%
Child
66%
Donor
66%
Relapse
66%
Diseases
33%
Combination Therapy
33%
Acute Myeloid Leukemia
33%
Bone Marrow Transplantation
33%
Leukemia
33%
Mononuclear Cell
33%
Tretinoin
33%
Fludarabine
33%
Peripheral Blood Stem Cell
33%
Farnesyltransferase Inhibitor
33%
Allogeneic Stem Cell Transplantation
33%
Mixed Myelodysplastic Myeloproliferative Disease
33%
Donor Lymphocyte Infusion
33%
Age
33%
Biochemistry, Genetics and Molecular Biology
Relapse
66%
Clofarabine
66%
Retinoic Acid
33%
Cytogenetics
33%
Myeloid
33%
Farnesyltransferase
33%
Fludarabine
33%
Age
33%
Allogeneic Stem Cell Transplantation
33%
Nursing and Health Professions
Juvenile Myelomonocytic Leukemia
100%
Tipifarnib
100%
Donor Lymphocyte Infusion
33%
Retinoic Acid
33%
Protein Farnesyltransferase Inhibitor
33%
Mixed Myelodysplastic Myeloproliferative Disease
33%
Immunology and Microbiology
Transplantation
100%
White Blood Cell
33%
Mononuclear Cell
33%
Myeloid
33%
Peripheral Blood Stem Cell
33%
Allogeneic Stem Cell Transplantation
33%
Age
33%
Pharmacology, Toxicology and Pharmaceutical Science
Juvenile Myelomonocytic Leukemia
100%
Mixed Myelodysplastic Myeloproliferative Disease
33%